Contribution: Industrial Research Assistance Program – Contributions to Firms
CCOA Therapeutics Inc
$50,000.00
Regulatory strategy and plan to support commercialization strategy
FY 2020-21 · 2020-09-01
Summary
The project is to develop global regulatory strategy for therapeutics, in vitro diagnostics, natural health products, and laboratory research reagents of CCOA Therapeutics (CCOA). This strategy will allow CCOA to understand all regulatory requirements, costs, timelines, resources required, risks, areas to monitor, potential hurdles. This project is also to build a Quality Management System in CCOA and development of SOPs.
Department
Program
Industrial Research Assistance Program – Contributions to FirmsIndustrial Research Assistance Program-Contributions to Firms (linked with high confidence)
Recipient
Location
Toronto|Toronto, Ontario, Canada
Recipient Type
For-profit organization
Business Number
780647129
Type
Contribution
Source
Proactive Disclosure - Grants and Contributions
Amendments
Each version of the agreement as published, oldest first, with its total as of that version. The amount above is the latest.
| Amendment | Date | Fiscal Year | Total |
|---|---|---|---|
| 0 | 2020-09-01 | 2020-21 | $50,000.00 |
| 1 | 2020-09-01 | 2020-21 | $50,000.00 |
As published
Additional Information
This agreement has been amended 1 time(s). The end date of this agreements has been modified by 15 days.
Additional Information (French)
Cet accord a été modifié 1 fois La date de fin du présent accord a été changé de 15 jours.
Agreement End Date
2021-03-15
Agreement Number
955843
Agreement Start Date
2020-09-01
Agreement Title
Regulatory strategy and plan to support commercialization strategy
Agreement Title (French)
Stratégie réglementaire et plan de soutien à la stratégie de commercialisation
Agreement Type
Contribution
Agreement Value
$50,000.00
Amendment Date
2021-01-26
Amendment Number
1
Coverage
IRAP Contributions to Firms projects stimulate wealth creation for Canada through technological innovation. | Les projets des Contributions aux entreprises stimulent la création de richesse au Canada grâce à l’innovation technologique.
Description
The project is to develop global regulatory strategy for therapeutics, in vitro diagnostics, natural health products, and laboratory research reagents of CCOA Therapeutics (CCOA). This strategy will allow CCOA to understand all regulatory requirements, costs, timelines, resources required, risks, areas to monitor, potential hurdles. This project is also to build a Quality Management System in CCOA and development of SOPs.
Description (French)
Le projet consiste à élaborer une stratégie réglementaire globale pour les produits thérapeutiques, les diagnostics in vitro, les produits de santé naturels et les réactifs de recherche en laboratoire de CCOA Therapeutics (CCOA). Cette stratégie permettra à CCOA de comprendre toutes les exigences réglementaires, les coûts, les délais, les ressources nécessaires, les risques, les domaines à surveiller et les obstacles potentiels. Ce projet vise également à mettre en place un système de gestion de la qualité au sein de la CCOA et à élaborer des procédures opérationnelles normalisées.
Expected Results
The purpose of IRAP Contributions to Firms is to support research, development, adoption and/or adaptation of innovative or technology-driven new or improved products, services or processes in Canada up to their commercialization
Expected Results (French)
Le PARI, par le biais des Contributions aux entreprises, vise à appuyer la recherche, le développement, l’adaptation et/ou l’adoption au Canada de produits, de services ou de processus novateurs ou axés sur des technologies nouvelles ou améliorées, et ce jusqu’à leur commercialisation
Federal Riding
Toronto Centre
Federal Riding (French)
Toronto-Centre
Federal Riding Number
35108
NAICS Code
3254
Organization Code
nrc-cnrc
Organization
National Research Council Canada | Conseil national de recherches Canada
Program Name
Industrial Research Assistance Program – Contributions to Firms
Program Name (French)
Programme d’aide à la recherche industrielle – Contributions aux entreprises
Program Purpose
The purpose of IRAP Contributions to Firms is to support research, development, adoption and/or adaptation of innovative or technology-driven new or improved products, services or processes in Canada up to their commercialization
Program Purpose (French)
Le PARI, par le biais des Contributions aux entreprises, vise à appuyer la recherche, le développement, l’adaptation et/ou l’adoption au Canada de produits, de services ou de processus novateurs ou axés sur des technologies nouvelles ou améliorées, et ce jusqu’à leur commercialisation
Recipient Business Number
780647129
Recipient City
Toronto|Toronto
Recipient Country
CA
Recipient Legal Name
CCOA Therapeutics Inc
Recipient Operating Name
CCOA Therapeutics Inc
Recipient Postal Code
M5B 1T8
Recipient Province or Territory
ON
Recipient Type
F
Reference Number
172-2020-2021-Q2-955843
